Yuva Biosciences' proprietary MitoNova™ AI platform identified small-molecule candidates that were biologically validated in primary human ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

In preclinical work and a small clinical trial, adding probenecid to the only approved PKD drug, tolvaptan, cut patients’ ...

A Cleveland-led team from University Hospitals, Case Western Reserve University and the Louis Stokes VA has identified a ...

Researchers found that World Trade Center responders with PTSD showed molecular changes associated with faster biological ...

The Trump administration has been scrutinizing the University of California, Berkeley, which insists its new program will be ...

A study of World Trade Center responders found that PTSD is associated with molecular changes linked to accelerated biological aging and a higher risk of chronic disease. The study, led by Stony Brook ...

Last week, the Trump administration issued controversial new interagency agreements moving the office for civil rights and ...

Level Agency, a performance-driven digital marketing agency, in partnership with PubMatic, the leading AI-powered ad tech company delivering digital advertising performance, today announced the ...

Here’s something most digital PR agencies won’t tell you upfront: the metrics they highlight in their monthly reports are not ...

Recent public comments made about AI suggest that Americans have difficulty with the implications of linear time. This is odd given that its conception is largely Western and is centered on the clock ...

The VICTORY-RCT study will evaluate an interdisciplinary treatment model for veterans and first responders with traumatic ...